2023年中国医用内窥镜市场增速报告：医疗资源下沉，国产品牌带动内窥镜行业高速稳定增长

Investment Rating - The report indicates a positive investment outlook for the endoscope industry in China, highlighting a stable growth trajectory driven by domestic brands and increasing healthcare demands [1]. Core Insights - The Chinese medical endoscope market experienced a year-on-year growth of 11.91% in 2023, with a market size estimated at approximately 34.943 billion yuan by the end of the year [4][6]. - The compound annual growth rate (CAGR) of the endoscope market from 2019 to 2023 exceeded 11%, reflecting robust market dynamics [4]. - The growth of the endoscope market is significantly influenced by the downward shift of medical resources, domestic brand development, and continuous technological advancements [2][4]. Market Performance - The endoscope market in China showed stable monthly performance in 2023, with significant growth in the first quarter, driven by favorable policies such as fiscal interest subsidies for medical equipment purchases [7][11]. - In 2023, 15 provinces and regions in China saw their endoscope market sizes exceed 1 billion yuan, with Guangdong being the only province surpassing 3 billion yuan [11][15]. - The growth rate of endoscope procurement varied significantly across different hospital tiers, with county hospitals emerging as a new growth point due to supportive policies [15][18]. Product Segmentation - Emerging product segments such as ductoscopes, bronchoscopes, and cystoscopes are leading the growth, driven by advancements in imaging quality and the promotion of minimally invasive surgeries [22]. - Domestic brands are becoming the main growth drivers in the endoscope market, with significant growth rates exceeding 50% in several product categories, including cystoscopes and ductoscopes [22][26]. - The report highlights that domestic brands occupy over 80% of the market share in various endoscope segments, indicating a strong domestic manufacturing presence [26][28].